Medical device maker Sirtex Medical Limited (ASX: SRX) appears to have moved back into the takeover spotlight with reports in The Australian newspaper suggesting that global giant Bayer is running the ruler over the Australian-based business.
Indeed, a merger between the two entities has been spoken about for some time with reports from Bloomberg dating back to September 2012 speculating about a tie-up. Since then, Sirtex’s stock has more than tripled in price from $8.40 to trade at $28 (down from a 52-week high of $39.95) as sales of its core SIR-Spheres microspheres product have continued to skyrocket.
Help employers find you! Check out all the jobs and post your resume.
